• 1:15pm2:45pm

    Sunday 25 October

  • Virtual Lunch Symposium

    Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach

    This Lilly satellite symposium will explore the integrated approach to improving our understanding of the impact of specific domains of chronic systemic disease, like Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis on the every-day-life of our patients.

    The expert panel of presenters will review the recent improvements in patient management, as well as those areas that remain open to improvement, in the context of the current and emerging molecular mechanism of JAK inhibition and IL17 inhibition.

    The symposium will be chaired by Prof. Kunihiro Yamaoka (Tokyo, Japan) and will address two key areas:

    1. Emerging learnings in PsA, AS and nr-axSpA: From clinical trials to clinical practice

    Speaker: Prof. Lars Erik Kristensen (Copenhagen, Denmark) will share the most up-to-date data for Ixekizumab from the SPIRIT and COAST trial programmes and discuss how these results inform the management of patients with Psoriatic Arthritis and Axial Spondyloarthritis in clinical practice.

    2.Challenges and opportunities in the treatment of RA: The role of JAK inhibitors

    Speaker: Prof. Andrew Ostör (Melbourne, Australia) will share the most up-to-date data for Baricitinib, elaborating on its use in daily practice, and discuss the placement of JAK inhibitors in the treatment algorithm for Rheumatoid Arthritis.

    The symposium will close with a panel discussion for any unanswered questions.

    We hope that you find this symposium a valuable forum for discussing the impact and areas of improvement in the treatment of rheumatic disease.

    Session Speakers
  • Professor Kunihiro Yamaoka

    Division of Rheumatology, Kitasato University Hospital, Japan

  • Professor Lars Erik Kristensen

    Parker Institute, University of Copenhagen, Copenhagen, Denmark

  • Professor Andrew Ostör

    Cabrini Medical Centre; Emeritus Research, Melbourne, Australia

  • Session Sponsor
  • Eli Lilly Japan K.K.